$CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Rep. Jefferson Shreve disclosed that the filer purchased · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Pharma & Biotech
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Transactions involving this ticker in readable 2013–2026 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.
3
Purchases
2
Sales
3
Filers
4
Reports
Transaction history
Rep. Jefferson Shreve disclosed that the filer purchased · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Rep. Jefferson Shreve disclosed that the filer sold · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Rep. Rob Bresnahan disclosed that the filer sold · $1,001 – $15,000 · Pharma & Biotech
View transaction source status →Rep. Rob Bresnahan disclosed that the filer purchased · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Rep. Julie Johnson's filing reports that a joint account purchased · $1,001 – $15,000 · Pharma & Biotech
View transaction source status →Rep. Lois Frankel disclosed that the filer sold · $1,001 – $15,000
View transaction source status →Rep. Lois Frankel disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Rep. Zoe Lofgren's filing reports that a spouse account sold · $1,001 – $15,000
View transaction source status →Rep. Zoe Lofgren disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Rep. Lamar Smith disclosed that the filer sold · $1,001 – $15,000
View transaction source status →Rep. Thomas MacArthur disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Rep. Thomas MacArthur disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Rep. Thomas MacArthur disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Rep. Thomas MacArthur disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →